<?xml version="1.0" encoding="UTF-8"?><CodeSystem xmlns="http://hl7.org/fhir"><id value="v3-substanceAdminSubstitution"/><meta><lastUpdated value="2016-11-11T00:00:00.000+11:00"/></meta><extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status"><valueString value="External"/></extension><extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"><valueInteger value="0"/></extension><url value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/><identifier><system value="urn:ietf:rfc:3986"/><value value="urn:oid:2.16.840.1.113883.5.1070"/></identifier><version value="2016-11-11"/><name value="v3 Code System substanceAdminSubstitution"/><status value="active"/><experimental value="false"/><date value="2016-11-11T00:00:00+11:00"/><publisher value="HL7, Inc"/><contact><telecom><system value="url"/><value value="http://hl7.org"/></telecom></contact><description value=" Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided."/><caseSensitive value="true"/><valueSet value="http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution"/><hierarchyMeaning value="is-a"/><content value="complete"/><property><code value="notSelectable"/><uri value="http://hl7.org/fhir/concept-properties#notSelectable"/><description value="Indicates that the code is abstract - only intended to be used as a selector for other concepts"/><type value="boolean"/></property><concept><code value="_ActSubstanceAdminSubstitutionCode"/><display value="ActSubstanceAdminSubstitutionCode"/><definition value="Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects."/><property><code value="notSelectable"/><valueBoolean value="true"/></property><concept><code value="E"/><display value="equivalent"/><definition value="Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product."/><concept><code value="EC"/><display value="equivalent composition"/><definition value="Description: &#xA;                        &#xD;&#xA;&#xA;                        Substitution occurred or is permitted with another product that is a:&#xD;&#xA;&#xA;                        &#xA;                           pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester&#xA;                           pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration&#xA;                        &#xA;                        &#xA;                           Examples: &#xA;                        &#xD;&#xA;&#xA;                        &#xA;                           &#xA;                              Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate&#xA;                           &#xA;                              Pharmaceutical equivalent: Lisonpril for Zestril"/><concept><code value="BC"/><display value="brand composition"/><definition value="Description: &#xA;                        &#xD;&#xA;&#xA;                        Substitution occurred or is permitted between equivalent Brands but not Generics&#xD;&#xA;&#xA;                        &#xA;                           Examples: &#xA;                        &#xD;&#xA;&#xA;                        &#xA;                           Zestril  for Prinivil&#xA;                           Coumadin for Jantoven"/></concept><concept><code value="G"/><display value="generic composition"/><definition value="Description: Substitution occurred or is permitted between equivalent Generics but not Brands&#xD;&#xA;&#xA;                        &#xA;                           Examples: &#xA;                        &#xD;&#xA;&#xA;                        &#xA;                           Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)"/></concept></concept><concept><code value="TE"/><display value="therapeutic alternative"/><definition value="Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.&#xD;&#xA;&#xA;                        &#xA;                           Examples: &#xA;                        &#xD;&#xA;&#xA;                        &#xA;                           ranitidine for Tagamet"/><concept><code value="TB"/><display value="therapeutic brand"/><definition value="Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics&#xD;&#xA;&gt;&#xA;                           Examples: &#xA;                        &#xD;&#xA;&#xA;                        &#xA;                           Zantac for Tagamet"/></concept><concept><code value="TG"/><display value="therapeutic generic"/><definition value="Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands&#xD;&#xA;&gt;&#xA;                           Examples: &#xA;                        &#xD;&#xA;&#xA;                        &#xA;                           Ranitidine  for cimetidine"/></concept></concept></concept><concept><code value="F"/><display value="formulary"/><definition value="Description: This substitution was performed or is permitted based on formulary guidelines."/></concept><concept><code value="N"/><display value="none"/><definition value="No substitution occurred or is permitted."/></concept></concept></CodeSystem>